High-throughput alternative splicing quantification by primer extension and matrix-assisted laser desorption/ionization time-of-flight mass spectrometry

被引:28
作者
McCullough, RM
Cantor, CR
Ding, CM
机构
[1] Chinese Univ Hong Kong, Prince Wales Hosp, Ctr Emerging Infect Dis, Sch Publ Hlth,Fac Med, Shatin, Hong Kong, Peoples R China
[2] Program Mol & Cellular Biol & Biochem, Boston, MA 02215 USA
[3] Ctr Adv Biotechnol, Boston, MA 02215 USA
关键词
D O I
10.1093/nar/gni098
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Alternative splicing is a significant contributor to transcriptome diversity, and a high-throughput experimental method to quantitatively assess predictions from expressed sequence tag and microarray analyses may help to answer questions about the extent and functional significance of these variants. Here, we describe a method for high-throughput analysis of known or suspected alternative splicing variants (ASVs) using PCR, primer extension and matrix-assisted laser desorption ionization time-of-flight mass spectrometry (MALDI-TOF MS). Reverse-transcribed mRNA is PCR amplified with primers surrounding the site of alternative splicing, followed by a primer extension reaction designed to target sequence disparities between two or more variants. These primer extension products are assayed on a MALDI-TOF mass spectrometer and analyzed automatically. This method is high-throughput, highly accurate and reproducible, allowing for the verification of the existence of splicing variants in a variety of samples. An example given also demonstrates how this method can eliminate potential pitfalls from ordinary gel electrophoretic analysis of splicing variants where heteroduplexes formed from different variants can produce erroneous results. The new method can be used to create alternative variant profiles for cancer markers, to study complex splicing regulation, or to screen potential splicing therapies.
引用
收藏
页码:1 / 9
页数:9
相关论文
共 41 条
[31]  
Tu YP, 1998, CANCER RES, V58, P256
[32]  
Ulaner GA, 1998, CANCER RES, V58, P4168
[33]  
Ulaner GA, 2000, INT J CANCER, V85, P330, DOI 10.1002/(SICI)1097-0215(20000201)85:3<330::AID-IJC6>3.0.CO
[34]  
2-U
[35]   Position and degree of mismatches and the mobility of DNA heteroduplexes [J].
Upchurch, David A. ;
Shankarappa, Raj ;
Mullins, James I. .
NUCLEIC ACIDS RESEARCH, 2000, 28 (12) :E69
[36]  
Wang ZN, 2003, CANCER RES, V63, P655
[37]  
Wright WE, 1996, DEV GENET, V18, P173
[38]   Discovery of novel splice forms and functional analysis of cancer-specific alternative splicing in human expressed sequences [J].
Xu, Q ;
Lee, C .
NUCLEIC ACIDS RESEARCH, 2003, 31 (19) :5635-5643
[39]   Genome-wide detection of tissue-specific alternative splicing in the human transcriptome [J].
Xu, Q ;
Modrek, B ;
Lee, C .
NUCLEIC ACIDS RESEARCH, 2002, 30 (17) :3754-3766
[40]   Variation in alternative splicing across human tissues [J].
Yeo, G ;
Holste, D ;
Kreiman, G ;
Burge, CB .
GENOME BIOLOGY, 2004, 5 (10)